Heterotopic gray matter, which previously had been associated with severe congenital malformations of the brain and developmental delay, was found without these associated conditions. The authors found ten cases of heterotopic gray matter on magnetic resonance (MR) images. The lesions had a signal intensity that was isointense compared with that of gray matter on T1, spin-density, and T2-weighted images. Nine of the ten cases were associated with a seizure disorder. The tenth case, discovered during a workup for metastatic lung disease, was confirmed with pathologic studies. Heterotopic gray matter is the presence of cortical neurons in an abnormal location, which may be periventricular (nodular) or within the white matter (laminar). A knowledge of heterotopic gray matter and its association with seizures may prevent the misinterpretation of findings on MR images.
Biogas can be generated from biomass in an anaer
The use of calcium channel blockers (CCB) as first-line antihypertensive therapy has correlated with increased incidences of CCB overdose. Massive CCB overdose proves difficult to manage as patients are prone to refractory distributive shock and noncardiogenic pulmonary edema. Extracorporeal membrane oxygenation (ECMO) has been a successful rescue therapy in CCB overdose. Veno-arterial (VA) ECMO has been the traditional modality used as it provides both cardiac and pulmonary support. However, recent case reports have described successful use of veno-venous (VV) ECMO for CCB overdose when cardiac function is preserved. We present a case of amlodipine overdose where VV ECMO was used instead of VA ECMO. This decision was guided by a point of care ultrasound (POCUS) exam that demonstrated a hyperdynamic left ventricle (LV) and normal right ventricle (RV) function immediately prior to cannulation. The patient subsequently improved, was decannulated, and survived to hospital discharge. CASE PRESENTATION: A 52-year-old male intentionally overdosed with amlodipine (750mg total). Emergency medical services were notified and transported the patient to the nearest critical access hospital. The patient became hypoxic, developed multipressor shock and met criteria for severe acute respiratory distress syndrome. On hospital day two the patient remained hypoxic despite an FiO2 of 1.0, deep sedation, neuromuscular blockade (NMB) and prone positioning. His shock was refractory despite infusions of norepinephrine, epinephrine, vasopressin and phenylephrine in addition to stress dose steroids and methylene blue. Our ECMO team was consulted for intervention. Prior to cannulation, cardiac POCUS revealed a hyperdynamic LV and preserved RV function. This guided our decision to implement VV instead of VA ECMO. The patient was cannulated then transported to our tertiary care institution. On ECMO day 2, the patient came off epinephrine and phenylephrine and NMB was discontinued. On ECMO day 4, the patient remained on norepinephrine alone and followed simple commands during a sedation holiday. On ECMO day 7 the patient no longer required vasopressors and was decannulated. The patient underwent tracheostomy placement, was placed on a long-term ventilator wean and discharged on hospital day 21.DISCUSSION: CCB overdose leading to refractory shock presents a difficult challenge for clinicians. There is promising data regarding the use of VA ECMO and, recently, VV ECMO as a rescue treatment in addition to supportive critical care in these cases. Selection of the appropriate ECMO modality prior to cannulation is paramount to optimize cardiopulmonary support. CONCLUSIONS:We assert that this case demonstrates the potential for utilizing POCUS as a tool to help decide what ECMO modality to use in patients with CCB overdose. Further study into POCUS as a means of determining ECMO modality is warranted.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.